| Issue | Title | |
| Vol 25, No 1 (2024) | Optimizing Treatment of Schizophrenia: Clinical and Economical Potential for Patient Switching to Long‑Acting Injectables | Abstract HTML PDF |
| Orietta Zaniolo, Silvia Maffezzoli, Massimiliano Povero, Lorenzo Pradelli | ||
| Vol 22, No 1 (2021) | Osteoarthritis in Italy: Impact on Health-Related Quality of Life and Health Care Resources | Abstract HTML PDF |
| Patrizia Berto, Maria Domenica Sanna, James Jackson, Mia Berry, Jessica Jackson | ||
| Vol 3, No 4 (2002) | Osteoporosi: la malattia e il suo costo sanitario | Abstract PDF |
| Gianpaolo Zara, Carlo Della Pepa, Lorenzo Pradelli, Mario Eandi | ||
| Vol 12, No 3S (2011) | Palivizumab e virus respiratorio sinciziale: una panoramica | Abstract PDF |
| Paolo Manzoni | ||
| Vol 12, No 3S (2011) | Palivizumab nella profilassi del virus respiratorio sinciziale: analisi di impatto sul budget del SSN italiano | Abstract PDF |
| Daniela Roggeri | ||
| Vol 8, No 2 (2007) | Palonosetron in the prevention of chemotherapy-induced nausea and vomiting in Italy: pharmacoeconomic and clinical aspects | Abstract PDF |
| Lorenzo Pradelli, Mario Eandi | ||
| Vol 4, No 1 (2003) | Parecoxib nel trattamento del dolore postoperatorio: considerazioni farmacoeconomiche | Abstract PDF |
| Lorenzo Pradelli, Mario Eandi | ||
| Vol 5, No 4 (2004) | Parecoxib nel trattamento del dolore post-operatorio: considerazioni farmacoeconomiche | Abstract PDF |
| Federica Mathis, Lorenzo Pradelli, Mario Eandi | ||
| Vol 5, No 1 (2004) | Parnaparin: confronto con le altre eparine a basso peso molecolare | Abstract PDF |
| Lorenzo Pradelli, Mario Eandi | ||
| Vol 6, No 3 (2005) | Parnaparin: confronto con le altre eparine a basso peso molecolare | Abstract PDF |
| Lorenzo Pradelli | ||
| Vol 9, No 1 (2008) | Parnaparin: review of the literature | Abstract PDF |
| Lorenzo Pradelli | ||
| Vol 16, No 2 (2015) | Patient reported outcomes to support drug development decision making | Details HTML PDF |
| Annabel Nixon, Diane Wild, Willie Muehlhausen | ||
| Vol 8, No 1 (2007) | Pay-back direct to Regions: a new possibility for companies | Details PDF |
| Orietta Zaniolo | ||
| Vol 9, No 4 (2008) | Peg-interferon plus ribavirin in chronic hepatitis C: cost-efficacy and pharmacoutilization in clinical practice | Abstract PDF |
| Luisa Cavalletto, Elisabetta Bernardinello, Giulio Diodati, Enzo Raise, Angelo Gatta, Liliana Chemello | ||
| Vol 13, No 4 (2012) | Perceval Sutureless valves in isolated and concomitant AVR procedures: an economic model shows overall decrease of costs for isolated or combined operations | Abstract HTML PDF |
| Lorenzo Pradelli, Orietta Zaniolo | ||
| Vol 1, No 1 (2000) | Percorsi diagnostico-terapeutici nella gestione dei pazienti affetti da polmonite acquisita in comunità | Abstract PDF |
| Mario Eandi | ||
| Vol 19, No 1 (2018) | Personalized medicine: biomarkers and companion diagnostics | Abstract HTML PDF |
| Renato Bernardini, Giovanni Gancitano, Angela Balice, Rosaria Di Mauro, Giuseppina Cantarella, Matteo Dionisi | ||
| Vol 7, No 3 (2006) | Pharmacoeconomic analysis of biological treatments for psoriatic arthritis | Abstract PDF |
| Mario Eandi, Carlo Salvarani | ||
| Vol 8, No 2 (2007) | Pharmacoeconomic analysis of long term use of darbepoetin-α in treating chronic nephropathy-induced anemia in dialysed patients | Abstract PDF |
| Nicola Giotta, Ercole Biamino, Mario Eandi | ||
| Vol 9, No 3 (2008) | Pharmacoeconomic analysis of valsartan for the treatment of chronic congestive heart failure in Italy | Abstract PDF |
| Sergio Iannazzo, Lorenzo Pradelli, Orietta Zaniolo | ||
| Vol 12, No 3 (2011) | Pharmacoeconomic aspects of poor adherence to treatment in multiple sclerosis management | Abstract HTML PDF |
| Mario Eandi | ||
| Vol 15, No 4 (2014) | Pharmacoeconomic aspects related to the 13-valent pneumococcal conjugate vaccine: preliminary analysis of the data from the ASL of Viterbo | Abstract HTML PDF |
| Silvia Dari, Flavia Verginelli, Silvia Aquilani | ||
| Vol 12, No 1 (2011) | Pharmacoeconomic comparison of ziprasidone with other atypical oral antipsychotic agents in schizophrenia | Abstract PDF |
| Andrea Fagiolini, Alice Matone, Claudio Gaz, Simona Panunzi, Andrea De Gaetano | ||
| Vol 10, No 2 (2009) | Pharmacoeconomic evaluation of influenza vaccination programs in elderly in Italy | Abstract PDF |
| Sergio Iannazzo, Viola Sacchi | ||
| Vol 11, No 1 (2010) | Pharmacoeconomic evaluation of the costs incurred by the ASP Messina for home therapy with liquid oxygen | Abstract PDF |
| Salvatore Coppolino | ||
| Vol 7, No 1 (2006) | Pharmacoeconomic profile of vitamin D3: in the prevention of osteoporosis | Abstract PDF |
| Orietta Zaniolo | ||
| Vol 7, No 4 (2006) | Pharmacoutilization of anti-inflammatory and gastroprotective drugs in patients with osteoarthritis: comparison between COXIBs and conventional NSAIDs by using administrative records | Abstract PDF |
| Luca Degli Esposti, Mirko Di Martino, Guido Didoni, Chiara Veronesi, Stefania Saragoni, Stefano Buda | ||
| Vol 13, No 2S (2012) | Piemonte | Abstract HTML PDF |
| Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni | ||
| Vol 9, No 1S (2008) | Piemonte | Abstract PDF |
| Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi | ||
| Vol 15, No 1 (2014) | Precision medicine: key applications and considerations for commercial success & market access | Details HTML PDF |
| Morten Søgaard, Indranil Bagchi, Mikael Dolsten | ||
| Vol 6, No 3 (2005) | Pregabalin versus gabapentin nel trattamento dei pazienti con neuropatia periferica: adattamento di un modello internazionale per la valutazione di costo/efficacia e costo/utilità alla realtà nazionale | Abstract PDF |
| Paolo Marchettini, Lisa Da Deppo, Lorenzo Pradelli | ||
| Vol 11, No 1 (2010) | Prevalence in the Italian regions of pain in patients with diabetic peripheral neuropathy (NDP) and the current costs of drug treatment for principals with specific indication | Abstract PDF |
| Luca Guidi | ||
| Vol 14, No 2S (2013) | Prevention of VTE in orthopedic surgery patients | Abstract HTML PDF |
| Federico Spandonaro, Rossella Letizia Mancusi, Lorenzo Terranova, Diana Giannarelli, Paolo Grossi, Davide Imberti, Emilio Mazza | ||
| Vol 6, No 3 (2005) | Prevenzione e terapia precoce del diabete mellito di tipo II: aspetti farmacoeconomici | Abstract PDF |
| Lorenzo Pradelli | ||
| Vol 13, No 2 (2012) | Pricing and reimbursement of innovative pharmaceuticals in France and the new healthcare reform | Abstract HTML PDF |
| Alexander Natz, Marie-Geneviève Campion | ||
| Vol 16, No 2 (2015) | Process reengineering: the experience of electrophisiology center of the Local Health Unit of Viterbo | Abstract HTML PDF |
| Mario Malavasi, Silvia Dari | ||
| Vol 4, No 4 (2003) | Profilo clinico ed economico di oxatomide | Abstract PDF |
| Lorenzo Pradelli, Mario Eandi | ||
| Vol 6, No 3 (2005) | Profilo farmacologico clinico e farmacoeconomico di un gel oftalmico a base di carbomero 974P e PVA (Siccafluid®) nella terapia della cheratocongiuntivite secca | Abstract PDF |
| Lorenzo Pradelli, Letizia Vacchini | ||
| Vol 5, No 2 (2004) | Profilo terapeutico e farmacoeconomico di linezolid | Abstract PDF |
| Mario Eandi | ||
| Vol 12, No 3 (2011) | Prophylaxis against febrile neutropenia with pegfilgrastim in Italy: a budget impact analysis | Abstract HTML PDF |
| Giovanni Rosti, Maria Lebboroni, Ario Cerchiari, Pablo Katz | ||
| Vol 9, No 1 (2008) | PROVE-IT trial: economic analysis | Abstract PDF |
| Simona de Portu, Sabato Montella, Simona Cammarota, Anna Citarella, Lorenzo G. Mantovani | ||
| Vol 13, No 2S (2012) | Puglia | Abstract HTML PDF |
| Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni | ||
| Vol 9, No 1S (2008) | Puglia | Abstract PDF |
| Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi | ||
| Vol 7, No 3 (2006) | Rational and irrational factors in the dynamics of pharmaceutical expenditure and in the drug price negotiation | Details PDF |
| Mario Eandi | ||
| Vol 6, No 2 (2005) | Razionalizzare la spesa ospedaliera: Day-Hospital, ADI, Hospice | Abstract PDF |
| Mario Eandi | ||
| Vol 21, No 1 (2020) | Real-life Diagnostic and Therapeutic Approach to CLL: A New Proposal from an Expert Panel in Tuscany Region | Abstract HTML PDF |
| Monica Bocchia, Alberto Bosi, Enrico Capochiani, Stefania Ciolli, Romano Danesi, Sara Galimberti, Alessandro Gozzetti, Sabrina Moretti, Ubaldo Occhini, Mario Petrini | ||
| Vol 15, No 2 (2014) | Real‑life cost and cost‑effectiveness for tiotropium 18 μg od monotherapy in moderate and severe COPD patients: a 48‑month survey | Abstract HTML PDF |
| Massimiliano Povero, Lorenzo Pradelli, Paola Turco, Roberto Walter Dal Negro | ||
| Vol 18, No 1 (2017) | Recently approved recombinant factor VIII (rFVIII) for the replacement treatment in patients with hemophilia A in Italy | Details HTML PDF |
| Daniela Paola Roggeri, Ezio Zanon, Alessandro Roggeri | ||
| Vol 11, No 1 (2010) | Regional control of pharmaceutical expenditure in the DL May 31, 2010 No 78 | Details PDF |
| Mario Eandi | ||
| Vol 13, No 2S (2012) | Regione “Test” | Abstract HTML PDF |
| Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni | ||
| Vol 12, No 3 (2011) | Report OsMed related to the first nine months of 2011 | Details HTML PDF |
| Ombretta Bandi | ||
| Vol 15, No 2 (2014) | Research gaps and Health Technology Assessment | Details HTML PDF |
| Leela Barham | ||
| Vol 7, No 2 (2006) | Resistenza all’uso degli ipoglicemizzanti orali nel trattamento del diabete tipo 2: uno studio multicentrico | Abstract PDF |
| Gianluca Falcitelli, Giuseppe Armentano, Corrado Pugliesi, Patrizio Tatti, Antonio Cimino | ||
| Vol 14, No 2 (2013) | Results of reference pricing and reimbursement discount rate schemes of Turkey | Abstract HTML PDF |
| Guvenc Kockaya, Kagan Atikeler, Esin Tuna, Pelin Kılıc, Pelin Tanyeri, Nurcan Umman, İsmail Mert Vural, Omer Altun, Akif Akbulat, Guven Artiran, Ercan Simsek, Hakkı Gursoz, Saim Kerman | ||
| Vol 5, No 1 (2004) | Rettifica al lavoro: considerazione cliniche ed economiche nel trattamento del cancro della prostata: analisi costo/efficacia di bicalutamide vs. flutamide in combinazione con LHRH | Details PDF |
| Sebastiano Maurizio Castorina | ||
| Vol 11, No 1 (2010) | Revisiting the role of a service-Day Hospital in infectious diseases, based on the natural history of HIV infection in the era of potent antiretroviral combination therapy | Abstract PDF |
| Roberto Manfredi | ||
| Vol 6, No 1 (2005) | Rifaximina nel trattamento della malattia diverticolare: potenziale terapeutico ed economico | Abstract PDF |
| Orietta Zaniolo, Mario Eandi | ||
| Vol 14, No 1 (2013) | Role of pharmacoeconomics in developing countries | Details HTML PDF |
| Amani Mori, Paul Gavaza, Bjarne Robberstad | ||
| Vol 9, No 2 (2008) | Rotigotine patches (Neupro) in early Parkinson’s disease | Abstract PDF |
| Viola Sacchi | ||
| Vol 13, No 2S (2012) | Sardegna | Abstract HTML PDF |
| Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni | ||
| Vol 9, No 1S (2008) | Sardegna | Abstract PDF |
| Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi | ||
| Vol 9, No 2 (2008) | Sartans: differences, similitudes and costs | Abstract PDF |
| Orietta Zaniolo, Sergio Iannazzo | ||
| Vol 13, No 2S (2012) | Sicilia | Abstract HTML PDF |
| Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni | ||
| Vol 9, No 1S (2008) | Sicilia | Abstract PDF |
| Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi | ||
| Vol 17, No 1S (2016) | Simulating the development and progression of Chronic Kidney Disease and osteoporosis in people living with HIV | Abstract HTML PDF |
| Silvano Adami, Paolo Maggi, Vincenzo Montinaro, Massimiliano Povero, Lorenzo Pradelli, Rita Bellagamba, Paolo Bonfanti, Antonio Di Biagio, Stefano Rusconi, Francesco Maria Di Campli, Giuseppe Forastieri, Michele Mancini | ||
| Vol 8, No 1 (2007) | Simvastatin: between clinics and health economics | Abstract PDF |
| Francesco Vittorio Costa, Orietta Zaniolo | ||
| Vol 9, No 1 (2008) | Solifenacin in overactive bladder syndrome: pharmacoeconomic analysis | Abstract PDF |
| Sergio Iannazzo, Lorenzo Pradelli | ||
| Vol 1, No 2 (2000) | Stato di salute degli italiani e prospettive di spesa sanitaria e farmaceutica | Abstract PDF |
| Mario Eandi | ||
| Vol 3, No 4 (2002) | Storia naturale dell’infiammazione allergica | Abstract PDF |
| Maria Angela Tosca, Giorgio Ciprandi | ||
| Vol 10, No 3 (2009) | Sugammadex in antagonism of neuromuscular block in anesthesia: a clinical and economic profile | Abstract PDF |
| Viola Sacchi, Sergio Iannazzo, Francesco Giunta | ||
| Vol 6, No 2 (2005) | Sulodexide: implicazioni cliniche ed economiche | Abstract PDF |
| Orietta Zaniolo, Mario Eandi | ||
| Vol 4, No 3 (2003) | Sviluppo e implementazione di un modello farmacoeconomico per valutare la costo efficacia di un ACE-inibitore nella prevenzione del rischio cardiovascolare | Abstract PDF |
| Sergio Iannazzo, Lorenzo Pradelli, Mario Eandi | ||
| Vol 7, No 1 (2006) | Taxane therapy in the adjuvant treatment of breast cancer in Italy: economic evaluation | Abstract PDF |
| Simona Ravera, Lorenzo G. Mantovani | ||
| Vol 9, No 4 (2008) | Telbivudine (Sebivo) in patients with hepatitis B virus (HBV) chronic infection | Abstract PDF |
| Viola Sacchi | ||
| Vol 7, No 2 (2006) | Telithromycin (Ketek®)in lower respiratory tract infections: economic aspects | Abstract PDF |
| Carlo Lazzaro | ||
| Vol 6, No 1 (2005) | Terapia del dolore: nuove norme e aspetti pratici per l’uso degli analgesici | Abstract PDF |
| Lorenzo Pradelli | ||
| Vol 6, No 1 (2005) | Terlipressina: profilo farmacologico clinico, terapeutico e farmacoeconomico nel trattamento delle varici esofagee | Abstract PDF |
| Lorenzo Pradelli | ||
| Vol 16, No 4 (2015) | The aging of Europe. The unexplored potential | Details HTML PDF |
| Mihajlo Jakovljevic | ||
| Vol 7, No 2 (2006) | The breakthrough of public pharmaceutical expenditure in 2005 | Details PDF PDF |
| Mario Eandi | ||
| Vol 7, No 3 (2006) | The clinical and economic value of lovastatin in the primary prevention of cardiovascular disease | Abstract PDF |
| Lorenzo Pradelli, Orietta Zaniolo | ||
| Vol 10, No 2 (2009) | The clinical and economic value of the dipeptide alanyl-glutamine in total parenteral nutrition of critically ill patients treated in intensive care units in Italy | Abstract PDF |
| Maurizio Muscaritoli, Lorenzo Pradelli, Orietta Zaniolo, Sergio Iannazzo, Mario Eandi | ||
| Vol 18, No 1 (2017) | The cost of a combination Anti-Retroviral Therapy (cART) optimization pathway as maintenance therapy in HIV-1 infected patients | Abstract HTML PDF |
| Roberto Ravasio, Fabio Rigo, Emanuela Lattuada, Ercole Concia, Massimiliano Lanzafame | ||
| Vol 13, No 1 (2012) | The cost-effectiveness of prevention: is an ounce of prevention worth a pound of cure? | Details HTML PDF |
| Steven Simoens | ||
| Vol 9, No 1 (2008) | The discovery of “sale amarissimo antifebbrile” (“bitter febrifugal saline”) by Bartolommeo Rigatelli, i.e. the origins of pharmacoeconomics | Abstract PDF |
| Piero Marson, Giampiero Pasero | ||
| Vol 21, No 1 (2020) | The Economic Burden of Different Multiple Sclerosis Courses: Analysis from Italian Administrative and Clinical Databases | Abstract HTML |
| Paolo Angelo Cortesi, Paolo Cozzolino, Ruggero Capra, Giancarlo Cesana, Lorenzo Giovanni Mantovani | ||
| Vol 15, No 1S (2014) | The economic impact associated with cerebrovascular events related to non-valvular atrial fibrillation (NVAF) in Italy: the role of apixaban | Details HTML PDF |
| Lorenzo Pradelli, Mario Calandriello, Roberto Di Virgilio, Marco Bellone, Marco Tubaro | ||
| Vol 13, No 2 (2012) | The effect of obesity upon Health Related Quality of Life (HRQoL): A comparison of the AQoL-8D and SF-36 instruments | Abstract HTML PDF |
| Munir Ahmed Khan, Jeff Richardson, Paul O'Brien | ||
| Vol 12, No 1 (2011) | The health and social costs of chronic kidney disease in Italy | Abstract PDF |
| Americo Cicchetti, Matteo Ruggeri, Paola Codella, Alessandro Ridolfi | ||
| Vol 7, No 4 (2006) | The health-economic models: practical aspects and management of uncertainty | Abstract PDF |
| Sergio Iannazzo | ||
| Vol 23, No 1 (2022) | The Importance of Real-World Evidence in Understanding Influenza Vaccine Effectiveness | Details HTML PDF |
| Pietro Ferrara, Lorenzo Giovanni Mantovani | ||
| Vol 24, No 1 (2023) | The Importance of the Pharmacoeconomic Analyses in Drug Negotiation. A Farewell Editorial | Details HTML PDF |
| Mario Eandi | ||
| Vol 20, No 1 (2019) | The Management of Psoriatic Arthritis in Italy: Organizational Impact Analysis of Optimized Pathways | Abstract HTML PDF |
| Umberto Restelli, Carlo Selmi, Valeria Pacelli, Davide Croce, Antonio Costanzo | ||
| Vol 10, No 4 (2009) | The pharmaceutical expenditure in Italy in 2009: toward regional federalism | Details PDF |
| Mario Eandi | ||
| Vol 13, No 2 (2012) | The public and patients should have their say in HTA | Details HTML PDF |
| Leela Barham | ||
| Vol 16, No 4 (2015) | The regulatory and Health Technology processes in Europe and drug market access. The case of cystic fibrosis | Abstract HTML PDF |
| Mayra Latorre Martinez, Pedro Serrano, Antonio Sarria Santamera | ||
| Vol 15, No 4 (2014) | The trend of pharmaceutical expenditure in Italy: from the report OsMed 2013 to the monitoring 2014 | Details HTML PDF |
| Mario Eandi | ||
| Vol 10, No 4 (2009) | The use of corticosteroids in patients with chronic obstructive pulmonary disease: epidemiological and economic aspects | Abstract PDF |
| Pablo M. Katz, Valeria Pegoraro | ||
| Vol 14, No 1S (2013) | The use of dexmedetomidine in intensive care sedation | Abstract HTML PDF |
| Massimo Antonelli, Giorgio Conti, Andrea Belisari, Lucia S. D'Angiolella, Lorenzo Mantovani, Sabato Montella, Patrizio Piacentini, Marco Ranieri | ||
| Vol 14, No 3 (2013) | The utility of a model-based cost-effectiveness analysis of degarelix versus leuprolide in the therapy of hormone-dependent advanced prostate cancer | Abstract HTML PDF |
| Massimo Perachino, Mario Eandi | ||
| Vol 20, No 1 (2019) | The Value and Sustainability of Ocrelizumab in Relapsing Multiple Sclerosis: A Cost-Effectiveness and Budget Impact Analysis | Abstract HTML PDF |
| Paolo Angelo Cortesi, Damiano Paolicelli, Marco Capobianco, Paolo Cozzolino, Lorenzo Giovanni Mantovani | ||
| 301 - 400 of 481 Items | << < 1 2 3 4 5 > >> | |
User
Font Size